{
    "clinical_study": {
        "@rank": "80447", 
        "acronym": "OK432", 
        "arm_group": {
            "arm_group_label": "OK432", 
            "arm_group_type": "Experimental", 
            "description": "Intracystic injection of OK432 under US  guiding"
        }, 
        "brief_summary": {
            "textblock": "Cohort study evaluate the efficacy treatment with OK-432 in cystic malformation of the head\n      and neck region.\n\n      The malformations are macrocystic and the preevaluation will include CT/MRI, US and blood\n      tests.\n\n      The injection will be in the OR under US  guided, maximal dose will be 0.2mg. The follow-up\n      will be of short term - till 30 days post injection and long term - follow-up wil be till 2\n      years."
        }, 
        "brief_title": "Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "CYSTIC MALFORMATION", 
        "condition_browse": {
            "mesh_term": "Congenital Abnormalities"
        }, 
        "detailed_description": {
            "textblock": "A cohort study, before the injection all the patients in the study will go through:\n\n        1. CT/MRI\n\n        2. US to estimate the cyst size\n\n        3. CBC, PT, PTT, INR, ASLO\n\n        4. ECG If the patient is qualified to the study the parent will sign on the inform\n           consent, than the child will be photographed AP and lateral.\n\n      The injection will be held in the OR under US guidance with 18q20 gauge needle, first all\n      the cyst contents will be sucked than the OK432 will be injected in.\n\n      After the injection the child will stay for one night if it was general anesthesia and 4\n      hours in the case of local anesthesia.\n\n      Short term follow - 3-5 days with the phone, up: till 30 days from the injection with US,\n      stills photo.\n\n      Long term follow-up: 6 months, 1 year, 2 years"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  LYMPHATIC MALFORMATION MACROCYSTIC OR MIXED WITH MORE THEN 50% MACROCYSTIC.\n\n          -  ONLY IN THE HEAD AND NECK AREA\n\n          -  TIME FROM OPERATION AT LEAST 6 MONTHS\n\n        Exclusion Criteria:\n\n          -  penicillin allergy\n\n          -  pregnancy\n\n          -  familial history of RF\n\n          -  Post streptococcal glomerulonephritis\n\n          -  Background illness-heart, kidney, lungs\n\n          -  fever > 38.5c in the op day\n\n          -  URT Infection\n\n          -  Family history of PANDAS"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "5", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699347", 
            "org_study_id": "CMC-11-0059-CTIL"
        }, 
        "intervention": {
            "arm_group_label": "OK432", 
            "description": "Intracystic injection of OK432 under US guiding", 
            "intervention_name": "Intracystic injection of OK432 under US guiding", 
            "intervention_type": "Drug", 
            "other_name": "OK432 (Picibanil)"
        }, 
        "intervention_browse": {
            "mesh_term": "Picibanil"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "OK432, CYSTIC MALFORMATION", 
        "lastchanged_date": "November 28, 2013", 
        "location": {
            "contact": {
                "email": "raanan@clalit.org.il", 
                "last_name": "Raanan Cohen-Kerem, MD", 
                "phone": "+97248250279"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel", 
                    "zip": "34362"
                }, 
                "name": "Department of Otolaryngology, Carmel Medical Center"
            }, 
            "investigator": {
                "last_name": "Raanan Cohen-Kerem, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432", 
        "overall_official": {
            "affiliation": "Carmel Medical Center, Haifa, Israel", 
            "last_name": "Raanan Cohen-Kerem, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "evaluation of the efficacy in treating cystic malformation with OK432 by measuring time that elapsed without recurrence", 
            "safety_issue": "Yes", 
            "time_frame": "4 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699347"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "TREATMENT SAFETY BY no. of participants with adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "4 YEARS"
        }, 
        "source": "Carmel Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Carmel Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}